141 related articles for article (PubMed ID: 31965261)
1. Key considerations in reviewing "a comparison of the outcomes between surgical resection and proton beam therapy for single primary hepatocellular carcinoma": the importance of scientific objective perspectives in clinical studies.
Okumura T; Makishima H; Sakurai H
Surg Today; 2020 Aug; 50(8):944-945. PubMed ID: 31965261
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the outcomes between surgical resection and proton beam therapy for single primary hepatocellular carcinoma.
Tamura S; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Murayama S; Uesaka K
Surg Today; 2020 Apr; 50(4):369-378. PubMed ID: 31602531
[TBL] [Abstract][Full Text] [Related]
3. Particle radiotherapy, a novel external radiation therapy, versus liver resection for hepatocellular carcinoma accompanied with inferior vena cava tumor thrombus: A matched-pair analysis.
Komatsu S; Kido M; Asari S; Toyama H; Ajiki T; Demizu Y; Terashima K; Okimoto T; Sasaki R; Fukumoto T
Surgery; 2017 Dec; 162(6):1241-1249. PubMed ID: 29031927
[TBL] [Abstract][Full Text] [Related]
4. Surgical spacer placement and proton radiotherapy for unresectable hepatocellular carcinoma.
Komatsu S; Hori Y; Fukumoto T; Murakami M; Hishikawa Y; Ku Y
World J Gastroenterol; 2010 Apr; 16(14):1800-3. PubMed ID: 20380016
[TBL] [Abstract][Full Text] [Related]
5. [A case report of multiple advanced hepatocellular carcinomas treated by combination therapy with hepatectomy and particle therapy].
Urade T; Kido M; Fukumoto T; Hori Y; Kusunoki N; Tsuchida S; Takahashi M; Tanaka M; Kuramitsu K; Tsugawa D; Gon H; Chuma M; Fukushima K; Matsumoto I; Ajiki T; Terashima K; Demizu Y; Murakami M; Ku Y
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2065-7. PubMed ID: 22202285
[TBL] [Abstract][Full Text] [Related]
6. Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution.
Nakano R; Ohira M; Kobayashi T; Ide K; Tahara H; Kuroda S; Shimizu S; Kimura T; Nagata Y; Aikata H; Chayama K; Ohdan H
Surgery; 2018 Aug; 164(2):219-226. PubMed ID: 29801728
[TBL] [Abstract][Full Text] [Related]
7. Liver function considerations for post-selective internal radiation therapy resection (hepatocellular carcinoma and metastatic colorectal cancer).
Sangro B
Future Oncol; 2014 Nov; 10(15 Suppl):57-9. PubMed ID: 25478769
[No Abstract] [Full Text] [Related]
8. Proton Beam Therapy and Carbon Ion Radiotherapy for Hepatocellular Carcinoma.
Apisarnthanarax S; Bowen SR; Combs SE
Semin Radiat Oncol; 2018 Oct; 28(4):309-320. PubMed ID: 30309641
[TBL] [Abstract][Full Text] [Related]
9. Charged-particle therapy for hepatocellular carcinoma.
Skinner HD; Hong TS; Krishnan S
Semin Radiat Oncol; 2011 Oct; 21(4):278-86. PubMed ID: 21939857
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of publications on charged particle therapy for hepatocellular carcinoma.
Igaki H; Mizumoto M; Okumura T; Hasegawa K; Kokudo N; Sakurai H
Int J Clin Oncol; 2018 Jun; 23(3):423-433. PubMed ID: 28871342
[TBL] [Abstract][Full Text] [Related]
11. Normal liver sparing by proton beam therapy for hepatocellular carcinoma: Comparison with helical intensity modulated radiotherapy and volumetric modulated arc therapy.
Kim JY; Lim YK; Kim TH; Cho KH; Choi SH; Jeong H; Kim DW; Park JH; Shin DH; Lee SB; Kim SS; Kim JY; Kim DY; Park JW
Acta Oncol; 2015 Nov; 54(10):1827-32. PubMed ID: 25765526
[No Abstract] [Full Text] [Related]
12. [Comparison of the effectiveness of percutaneous microwave ablation versus hepatectomy for hepatocellular carcinoma].
Sheng L; Wang Y; Jun D; Peihong W
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):301-7. PubMed ID: 26462897
[TBL] [Abstract][Full Text] [Related]
13. Liver phantom design and dosimetric verification in participating institutions for a proton beam therapy in patients with resectable hepatocellular carcinoma: Japan Clinical Oncology Group trial (JCOG1315C).
Nishio T; Tachibana H; Kase Y; Hotta K; Nakamura M; Tamura M; Terunuma T; Toshito T; Yamashita H; Ishikura S; Fuji H; Akimoto T; Nishimura Y
Radiother Oncol; 2019 Nov; 140():98-104. PubMed ID: 31265942
[TBL] [Abstract][Full Text] [Related]
14. Reply to comment on "Is surgical resection superior to proton beam therapy for operable hepatocellular carcinoma?".
Tamura S; Okamura Y
Surg Today; 2020 Dec; 50(12):1716. PubMed ID: 32219619
[No Abstract] [Full Text] [Related]
15. Validation of combination treatment with surgical spacer placement and subsequent particle radiotherapy for unresectable hepatocellular carcinoma.
Komatsu S; Terashima K; Matsuo Y; Takahashi D; Suga M; Nishimura N; Lee D; Tai K; Kido M; Toyama H; Demizu Y; Tokumaru S; Okimoto T; Sasaki R; Fukumoto T
J Surg Oncol; 2019 Aug; 120(2):214-222. PubMed ID: 31075183
[No Abstract] [Full Text] [Related]
16. Proton beam therapy for hepatocellular carcinoma.
Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.
Hsieh CE; Venkatesulu BP; Lee CH; Hung SP; Wong PF; Aithala SP; Kim BK; Rao A; Tung-Chieh Chang J; Tsang NM; Wang CC; Lee CC; Lin CC; Tseng JH; Chou WC; Wang YC; Krishnan S; Hong JH
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):73-86. PubMed ID: 30797890
[TBL] [Abstract][Full Text] [Related]
18. Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapy.
Mizumoto M; Oshiro Y; Okumura T; Fukuda K; Fukumitsu N; Abei M; Ishikawa H; Ohnishi K; Numajiri H; Tsuboi K; Sakurai H
Radiother Oncol; 2014 Oct; 113(1):54-9. PubMed ID: 25248924
[TBL] [Abstract][Full Text] [Related]
19. Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives.
Yoo GS; Yu JI; Park HC
World J Gastroenterol; 2018 Jul; 24(28):3090-3100. PubMed ID: 30065555
[TBL] [Abstract][Full Text] [Related]
20. Proton beam therapy for tumors of the upper abdomen.
Raldow A; Lamb J; Hong T
Br J Radiol; 2020 Mar; 93(1107):20190226. PubMed ID: 31430202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
